Safety and Tolerability of the Chymase Inhibitor Fulacimstat in Patients With Left Ventricular Dysfunction After Myocardial Infarction-Results of the CHIARA MIA 1 Trial

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

OriginalsprogEngelsk
TidsskriftClinical Pharmacology in Drug Development
Vol/bind8
Udgave nummer7
Sider (fra-til)942-951
Antal sider10
ISSN2160-763X
DOI
StatusUdgivet - 2019

ID: 222245848